Payments to Acquire Property, Plant, and Equipment of Editas Medicine, Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Editas Medicine, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Editas Medicine, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $114,000, a 94% decline year-over-year.
  • Editas Medicine, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $607,000, a 93% decline from 2024.
  • Editas Medicine, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $8,826,000, a 87% increase from 2023.
  • Editas Medicine, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $4,719,000, a 15% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Editas Medicine, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $607,000 -$8,219,000 -93% 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 $8,826,000 +$4,107,000 +87% 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2023 $4,719,000 +$601,000 +15% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2025 2024 FY
2022 $4,118,000 -$3,859,000 -48% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2025 2024 FY
2021 $7,977,000 +$815,000 +11% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $7,162,000 +$995,000 +16% 01 Jan 2020 31 Dec 2020 10-K 22 Feb 2023 2022 FY
2019 $6,167,000 +$1,413,000 +30% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $4,754,000 +$2,695,000 +131% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $2,059,000 -$1,434,000 -41% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $3,493,000 +$2,062,000 +144% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $1,431,000 +$214,000 +18% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018 2017 FY
2014 $1,217,000 01 Jan 2014 31 Dec 2014 10-K 03 Mar 2017 2016 FY

Editas Medicine, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $114,000 -$1,757,000 -94% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $1,871,000 +$31,000 +1.7% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q1 2023 $1,840,000 -$408,000 -18% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $2,248,000 +$2,164,000 +2576% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q1 2021 $84,000 -$2,068,000 -96% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $2,152,000 +$1,434,000 +200% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $718,000 -$293,000 -29% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $1,011,000 +$355,000 +54% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $656,000 -$287,000 -30% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q1 2016 $943,000 +$638,000 +209% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q1 2015 $305,000 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.